Learn how to build a self-hosted home server with Proxmox, a small PC, Ubiquiti networking, Jet KVM, and Tailscale for secure ...

In the previous article, I discussed the idea that "Kali Linux is not a scary OS." As a follow-up, this time we will move on to actually getting our hands dirty and building the environment. That said ...

本内容遵循CC 4.0 BY-SA版权协议 很多人第一次接触Kali Linux，脑子里想的第一件事就是“直接装成主力系统”。我劝你先冷静。Kali本质上是一套面向安全测试的专用系统，里面装了数百款工具 ...

This Cybersecurity Lab Setup project focuses on building a safe, isolated, and virtualized environment to simulate cyberattacks, analyze malware, perform vulnerability assessment and test defensive ...

本内容遵循CC 4.0 BY-SA版权协议 如果你对网络安全、渗透测试或者只是单纯想折腾一个“黑客”系统感到好奇，那么Kali Linux这个名字你一定不陌生。它集成了数百种安全审计和渗透测试工具，是 ...

Offensive Security has announced the release of Kali Linux 2026.2, the second update for this year of their security-focused Linux distribution. The new version introduces nine additional tools, ...

Offensive Security shipped Kali Linux 2026.2 on Monday, June 29, delivering the most technically disciplined point release the project has produced in recent memory. The update hands penetration ...

Kali Linux 2026.1 is now available, introducing eight new tools, a kernel upgrade to version 6.18, a refresh of the annual theme, and a new BackTrack mode for the Kali-Undercover feature. The Kali ...

Kali Linux 2026.1, the first release of the year, is now available for download, featuring 8 new tools, a theme refresh, and a new BackTrack mode for Kali-Undercover. Kali is a Linux distribution ...

Penetration testers running Kali Linux have a new release to work with. Version 2026.1 delivers the annual theme refresh, a new BackTrack-inspired mode in kali-undercover, eight tools added to the ...

March 23 (Reuters) - Kali Therapeutics said on Monday it has entered into a licensing agreement with French drugmaker Sanofi (SASY.PA), opens new tab to develop the privately held firm's experimental ...

Sanofi is no stranger to T-cell engagers, which remain a hot ticket for pharma dealmaking this year. (Photo by ALAIN JOCARD/AFP via Getty Images) Sanofi has returned to T-cell engager (TCE) territory ...